Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 1, 2011Clinical presentations to include 12-month data on fourth-generation SYNERGY™ Stent
Boston Scientific Corporation (NYSE: BSX) releases the schedule of its major events and product-related clinical research for the Cardiovascular...
-
Oct 27, 2011Video demonstration of CardioTeach™ app by Dr. Kenneth Stein available online
Boston Scientific Corporation (NYSE: BSX) introduces its CardioTeach™ iPad® app, an industry-first, free educational resource to help healthcare...
-
Oct 20, 2011
Boston Scientific Corporation (NYSE: BSX) announces financial results for the third quarter ended September 30, 2011, as well as updated sales and...
-
Oct 18, 2011
Boston Scientific Corporation (NYSE: BSX) has completed enrollment in a clinical trial to evaluate its WallFlex® Biliary RX Fully Covered Stent for...
-
Oct 17, 2011Company's everolimus-eluting platinum chromium stent now being marketed in world's second-largest DES market
Boston Scientific Corporation (NYSE: BSX) has begun a phased launch of its PROMUS Element™ Everolimus-Eluting Platinum Chromium Coronary Stent System...
-
Oct 14, 2011
Boston Scientific Corporation (NYSE: BSX) welcomes yesterday's introduction of the Medical Device Regulatory Improvement Act, sponsored by Sen. Amy...
-
Oct 11, 2011
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the third quarter ended September 30, 2011...
-
Oct 5, 2011Third-generation bare-metal stent designed to offer improved acute performance in treating patients with coronary artery disease
Boston Scientific Corporation (NYSE: BSX) has started patient enrollment in the OMEGA clinical trial, designed to evaluate the safety and effectiveness...
-
Sep 29, 2011Study designed to assess preliminary safety and efficacy of chronic vagal nerve stimulation in heart failure patients
Boston Scientific Corporation (NYSE: BSX) has enrolled the first patients in its NECTAR-HF (NEural Cardiac TherApy foR Heart Failure) clinical trial....
-
Sep 28, 2011
Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Court of Appeals for the Federal Circuit found in favor of the Company in a...
-
Sep 19, 2011Ultra-low profile, highly deliverable balloon dilatation catheter offers physicians exceptional performance in peripheral angioplasty procedures
Boston Scientific Corporation (NYSE: BSX) has launched its Coyote™ Balloon Catheter, a highly deliverable and ultra-low profile 0.014 inch balloon...
-
Sep 15, 2011Company supports women's health through online community launched by American Urogynecologic Society (AUGS) at annual meeting
Boston Scientific Corporation (NYSE: BSX) is further supporting the advancement of women's health as the founding sponsor of the American...
-
Sep 13, 2011Mahoney Has Served as Worldwide Chairman, Medical Device and Diagnostics Group, Johnson & Johnson
Attracting one of med-tech's most inspiring leaders, Boston Scientific Corporation (NYSE: BSX) has named Michael Mahoney, 46, as President of the...
-
Sep 9, 2011
Boston Scientific Corporation (NYSE: BSX) today issued the following statement from John Pedersen, Senior Vice President and President of the Company's...
-
Sep 2, 2011
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Morgan Stanley Global Healthcare Conference on September 14 in New York....
-
Sep 2, 2011
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Morgan Stanley Global Healthcare Conference on September 14 in New York....
-
Aug 10, 2011Company also introduces industry's first iPhone®/iPad® app for healthcare professionals using SCS
Boston Scientific Corporation (NYSE: BSX) has launched its Neuromodulation Learning Institute™ (NLI), a clinical education program and online...
-
Aug 9, 2011Company's fully covered metal stent now approved in Canada for use in treating benign biliary strictures
Natick, MA (August 9, 2011) – Boston Scientific Corporation’s (NYSE: BSX) WallFlex® Biliary RX Fully Covered Stent has received Health Canada approval for the treatment of benign biliary...
-
Aug 8, 2011
Boston Scientific Corporation (NYSE: BSX) today announces the U.S. Court of Appeals for the First Circuit has affirmed the dismissal of a...
-
Aug 8, 2011Investment supported by grant funding from Government through IDA Ireland
Clonmel, 8th August 2011 – Boston Scientific Corporation (NYSE: BSX) and Irish Minister for Jobs, Enterprise and Innovation, Richard Bruton TD, announced that the Company is investing €26...
-
Jul 28, 2011Company also announces new share repurchase, China investment and restructuring program
Boston Scientific Corporation (NYSE: BSX) today announces financial results for the second quarter ended June 30, 2011, as well as net sales and...
-
Jul 28, 2011
Boston Scientific Corporation's (NYSE: BSX) Board of Directors has approved a new program authorizing the repurchase of up to $1.0 billion of its...
-
Jul 27, 2011Investment to support development of local manufacturing capabilities and training center
Boston Scientific Corporation's (NYSE: BSX) Board of Directors has approved a five-year, $150 million investment in China to expand its commercial...
-
Jul 21, 2011
Boston Scientific Corporation (NYSE: BSX) announces that Fitch Ratings has upgraded the Company's corporate credit rating to an investment grade...
-
Jul 14, 2011
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the second quarter ended June 30, 2011 on...
-
Jul 12, 2011European ASTI study to evaluate new nitinol stent to treat carotid artery disease
Boston Scientific Corporation (NYSE: BSX) has completed patient enrollment in the ASTI post-market clinical follow-up study designed to evaluate its...
-
Jul 5, 2011Boston Scientific's Galway Site in Ballybrit Commercializes Innovative Mustang™ PTA Balloon Catheter
Galway, Ireland (July 5, 2011) -- Boston Scientific’s Galway site in Ballybrit is manufacturing and distributing the Company’s recently launched Mustang™ Percutaneous Transluminal...
-
Jul 4, 2011Expanded Heredia plant to manufacture a broad line of medical devices
San José, (July 4, 2011) Boston Scientific Corporation (NYSE: BSX) today announced that it has completed the expansion of its manufacturing facility in Heredia, Costa Rica. This initiative will...
-
Jun 30, 2011
Boston Scientific Corporation (NYSE: BSX) welcomes the recent landmark report to Congress by the Institute of Medicine (IOM) of the National Academy of...
-
Jun 30, 2011Detachable coils for peripheral embolization offer precise placement and control in coiling procedures
Boston Scientific Corporation (NYSE: BSX) today announced the immediate U.S. and European launch of its Interlock™ – 35 Fibered IDC™ Occlusion...
-
Jun 27, 2011
Boston Scientific Corporation (NYSE: BSX) today welcomed approval by the U.S. House of Representatives of the America Invents Act of 2011. The...
-
Jun 20, 2011Low-profile, high-pressure balloon offers physicians exceptional performance in a single platform for peripheral angioplasty procedures
Boston Scientific Corporation (NYSE: BSX) today announced the global launch of its Mustang™ PTA Balloon Catheter, a highly deliverable 0.035 inch...
-
Jun 16, 2011
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2011 Wells Fargo Securities Healthcare Conference on June 22 in Boston....
-
Jun 7, 2011
Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Court of Appeals for the Federal Circuit affirmed the decision of the U.S....
-
May 27, 2011Action affects products distributed in U.S. and its territories; Atlantis® SR Pro available immediately as a substitute
Boston Scientific Corporation (NYSE: BSX) today announced that it is voluntarily recalling all of its iCross™ Coronary Imaging Catheters used in...
-
May 25, 2011Boston Scientific becomes the first and only company to offer two distinct drug-eluting stents to treat small vessels
Boston Scientific Corporation (NYSE: BSX) today announced it has received approval from the U.S. Food and Drug Administration (FDA) to market its 2.25...
-
May 23, 2011New technology designed to improve lead anchoring for physicians to be introduced at INS World Congress
London, UK (May 23, 2011) – Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval of the Clik™ Anchor for its Precision Plus™ Spinal Cord Stimulator (SCS) System,...
-
May 23, 2011New technology designed to improve lead anchoring for physicians to be introduced at INS World Congress
London, UK (May 23, 2011) – Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval of the Clik™ Anchor for its Precision Plus™ Spinal Cord Stimulator (SCS) System,...
-
May 20, 201112-month clinical data demonstrate low adverse event rates for Boston Scientific's 2.25 mm PROMUS Element Platinum Chromium Stent
Boston Scientific Corporation (NYSE: BSX) today announced 12-month results from its PLATINUM Small Vessel study, demonstrating excellent...
-
May 18, 2011Results for Boston Scientific WATCHMAN device presented at EuroPCR
Boston Scientific Corporation (NYSE: BSX) today announced results from a clinical study evaluating the use of its WATCHMAN® Left Atrial...
-
May 16, 2011Five-year data from RISA Trial presented at ATS adds to clinical evidence showing long-term safety of Boston Scientific's Alair® Bronchial Thermoplasty System
Boston Scientific Corporation (NYSE: BSX) today announced long-term safety data from the Research in Severe Asthma (RISA) Trial, which...
-
May 11, 2011
Boston Scientific Corporation (NYSE: BSX) today announced that a jury in the District Court for the District of Delaware found that Cordis Corporation...
-
May 11, 2011Patients receive first device-based treatment for severe asthma
Natick, MA (May 11, 2011) -- Boston Scientific Corporation (NYSE: BSX) today announced the launch of its Alair® Bronchial Thermoplasty System in Canada. Doctors at Institut universitaire de...
-
May 10, 2011Elliott to remain on Board as non-executive director
Boston Scientific Corporation (NYSE: BSX) today announced that Ray Elliott will retire as President and Chief Executive Officer on December 31, 2011....
-
May 10, 2011Company sponsors additional efforts to promote education and awareness of severe asthma
Boston Scientific Corporation (NYSE: BSX) today announced its donation to the Asthma and Allergy Foundation of America (AAFA) to support education...
-
May 9, 2011Innovative Fine Needle Aspiration technology expands diagnostic capabilities in pancreas and gastrointestinal tract
Boston Scientific Corporation (NYSE: BSX) today announced the U.S. and international launch of its Expect™ Endoscopic Ultrasound Aspiration Needle,...
-
May 6, 2011World's smallest and thinnest high-energy CRT-Ds and ICDs offer new features to optimize patient management
Boston Scientific Corporation (NYSE: BSX) today announced the launch and first implants of its ENERGEN™ and PUNCTUA™ cardiac resynchronization...
-
May 5, 2011
Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of its ALTITUDE® Clinical Science program, which...
-
May 5, 2011
Boston Scientific Corporation (NYSE: BSX) today announced that it is offering a new warranty program in the U.S. that covers its cardiac...
-
May 4, 2011System used in 25,000 patient procedures at 600 facilities worldwide since 2007
Boston Scientific Corporation (NYSE: BSX) today announced several milestones in the adoption of its SpyGlass® Direct Visualization System since its...